Fineotex Chemical Confirms Full Deployment of Preferential Issue Funds

Fineotex Chemical Limited has confirmed the complete utilization of ₹150.85 crore raised through its recent preferential issue. The company submitted its Monitoring Agency Report for the quarter and year ended March 31, 2026, detailing the final deployment of these funds.

Fund Deployment Details

The report, prepared by ICRA Limited, validates that all net proceeds from the preferential issue, which concluded between July 12-19, 2024, have been spent as planned. The company had initially aimed to raise ₹218.11 crore, but an undersubscription resulted in net proceeds of ₹150.85 crore. As a result, the costs for the project objectives were revised downwards on a pro-rata basis.

By the deadline of March 31, 2026, the ₹150.85 crore was allocated across three key areas:

• ₹10.27 crore for Working Capital Requirement
• ₹124.48 crore for Business Expansion
• ₹16.09 crore for General Corporate Purposes

Fineotex Chemical stated that the timeline for completing the overall project objectives remains September 30, 2030, and the company is currently on track.

Investor Confidence and Execution

This confirmation serves as a crucial compliance document, reassuring investors and stakeholders that the capital raised has been effectively deployed towards the company's growth objectives. Meeting the fund utilization targets on schedule reinforces confidence in Fineotex Chemical's management and its capability to execute expansion plans.

Background and Strategy

Fineotex Chemical's strategic focus involves expanding its manufacturing capacities and enhancing its product portfolio within the specialty chemicals segment. The preferential issue was intended to secure the necessary capital for these growth ambitions. The company's commitment to scaling operations and meeting market demand was previously demonstrated by the inauguration of a new manufacturing facility in Ambernath in 2023.

Impact of Fund Utilization

The successful deployment of these funds is expected to boost investor confidence in the company's project execution. It should also strengthen the company's working capital position, supporting smoother daily operations. The expansion projects funded by this issue are now actively progressing or nearing completion as per allocation. Furthermore, Fineotex Chemical has met its regulatory compliance requirements for fund utilization reporting.

Considerations and Future Risks

Investors should note that the initial undersubscription of the preferential issue led to a pro-rata reduction in allocated costs for business expansion and working capital. This adjustment could potentially impact project scope or timelines if not managed skillfully. Moving forward, the successful execution of expansion plans and sustained market demand for specialty chemicals, especially amidst evolving industry dynamics, will be key factors to watch.

Peer Comparison

In the competitive specialty chemicals market, Fineotex Chemical is positioned alongside established players. Pidilite Industries Ltd is recognized for its strong brand equity in adhesives and construction chemicals, with a notable presence in textile chemicals. Atul Ltd operates across diverse chemical segments, including textiles, crop protection, and pharmaceuticals, and is noted for its research and development capabilities.

What to Watch Next

Investors will likely monitor future updates on the progress and milestones of the business expansion projects. Enhancements in operational and financial performance stemming from improved working capital management will also be important indicators. Any further disclosures from the Monitoring Agency regarding project completion status are also key points for observation.